YOUR PATIENT IS ELIGIBLE FOR COVID-19 MONOCLONAL ANTIBODY THERAPY.
PLEASE NOTE THAT AS OF 11/22/21, INFUSIONS WILL NOT BE DONE ON A ROUTINE DAILY BASIS.
INFUSION SCHEDULES WILL DEPEND ON STAFFING. PATIENT APPLICATIONS ARE BEING PRIORITIZED ACCORDING TO VACCINATION STATUS, AGE, AND RISK FACTORS.
PLEASE NOTE THAT AS OF 11/22/21, INFUSIONS WILL NOT BE DONE ON A ROUTINE DAILY BASIS.
INFUSION SCHEDULES WILL DEPEND ON STAFFING. PATIENT APPLICATIONS ARE BEING PRIORITIZED ACCORDING TO VACCINATION STATUS, AGE, AND RISK FACTORS.
THE APPLICATION IS FOUND BELOW. IMPORTANT NOTES:
- Applications must be received by 10 AM for review by GVH team to determine which patients will receive treatment as early as the next business day.
- GVH has limited supplies of the monoclonal antibody products. If more applications are received than monoclonal antibody doses at GVH, a first-come, first-served methodology may be used to determine who receives treatments.
- Patients will be assessed prior to treatment (ie. vital signs, days since symptom onset) to make sure they are still eligible for treatment.
- If you need a digital version of the monoclonal FDA Fact Sheet, see button below.
IF YOU ARE HAVING ISSUES PRINTING, GVH IT DEPARTMENT ADVISES USING THE GOOGLE CHROME OR MICROSOFT EDGE BROWSERS. INTERNET EXPLORER HAS KNOWN INCOMPATIBILITIES WITH PDFs
| MARCH 2022 MAB APP.pdf |